You are on page 1of 3

We released a research report on Caplin Point a few months back.

The company is into injectibles and is a major

player in the Latin American markets where any other Indian pharma company has not yet entered in a big way.
It's a small cap company and has given 300% returns since then. This stock still has huge potential going ahead.

We also like Suven Lifesciences which is giving 22% ROE since the last 2 years and is poised to grow in a big
way in the coming 2-3 years.

We have collated a list of four stocks from CLSA in the midcap space, which
can deliver up to 21% return in the next 12 months:

2. Buy Escorts, price target 180, time horizon 1 year

Introduction of high power and specialised tractors have continuously delivered high growth
for the company. We suggest you buy this mid cap stock in 2014 and hold for 1 year with a
price target of Rs. 180.
- See more at:

Finolex Inds- Market capitalization is about Rs 1,200 cr. The stock should do well and reach
close to Rs 205 -210 cr next year. The target price for the stock is Rs 100.

Suprajit Engineering will do about Rs 550 cr of revenue this year and is expected to do Rs
650 cr of business next year. Market captalisation is Rs 700 cr. It is a debt free company with a
decent cash flow. The target price for the stock is Rs 70.

VIP Industries for a target price of Rs 90, stop loss at Rs 67. Stock has broken out of an
inverse H&S pattern, neckline is at 70 levels.

TVS Motor Company is trading higher by 4% at Rs 89 after reporting 6% year-on-year growth in
two-wheeler sales in February 2014 to 170,293 units from 160,895 units during the same month
last year.



Top cement companies

Jyoti Strucutres Target price Rs 120 Upside 102 per cent

Jyoti Structures (JSL) is a leading player in the domestic transmission and distribution space. The company has
been widening its reach in the export market to offset the decline in domestic order flows. Its order book of Rs
48.5 billion (44 per cent exports) provides revenue visibility over the next 18 months. Going forward order inflows
would gain momentum as the new government ..

PTC India Fin Services Target price Rs 32 65 Upside 103 per cent

PTC India Financial Services is a niche play on revival in power capex. Under the new reform-oriented
government, the policy environment for power sector is expected to improve distinctly. Since inception, PFS has
witnessed rapid expansion in its loan book. With huge sanctions in place and likely improvement in project
execution as well as pipeline, the company is on cours ..

Kirloskar Oil Engines Target price Rs 485 Upside 104 per cent

Kirloskar Oil Engines is well placed to gain from the country's power deficit situation and an expected economic
revival. While the power deficit in the country is expected to improve over the longer term, we believe it would
continue to be strained in the shorter term. On the other hand, industrial activity is expected to see strong revival
in the near term.

JK Lakshmi Cement Target price Rs 433 Upside 106 per cent

Government emphasis on a) housing for all, b) 100 new cities, c) connecting major rivers and d) infrastructure
development like building ports and roads is most likely to boost the cement demand in the coming year.

As incremental capacity addition for the industry slows down and demand picks up, it would lead to better
capacity utilization for JK Lakshmi and thereby supp ..

Dhanuka Agritech Agriculture Target price Rs 800 Upside 101 per cent

Dhanuka Agritech (DAL) is a leading player in the agrochemical sector. DAL's inherent strength lies in its asset
light business model which has led to higher return on asset than the industry. The management's focus on
building strong distribution network while collaborating with major global chemical players to introduce high-
margin specialty products has paid rich di ..

Alembic Pharma Target Rs 550 Upside 104 per cent

Alembic Pharmaceuticals offers opportunity to play the growing domestic branded formulations market combined
with its US-centric international generics business. The latter has posted ~39% CAGR over FY12-14 and we
expect robust US-led momentum in international generics to continue while domestic branded formulations
growth would be closer to 20% over the next 2-3 years.

Our confi ..

Here is the list of top 7 mid-cap stocks that hit fresh 52-week highs on the Street:

Read more at:

Back home, among the key mid-cap gainers, AstraZeneca Pharma India has hit the upper circuit
filter of 20% at Rs 1,113 on the National Stock Exchange (NSE), after its Sweden-based parent
company AstraZeneca Pharmaceuticals AB suggested that it plans to delist companys equity
shares from the Indian stock exchanges.

TVS Motor Company is trading higher by 4% at Rs 89 after reporting 6% year-on-year growth in
two-wheeler sales in February 2014 to 170,293 units from 160,895 units during the same month
last year.

Monsanto India is locked in upper circuit for second day in a row, up 20% at Rs 1,613, also its
new high on the BSE, on reports that the Union ministry of environment and forests (MoEF) has
approved field trials of genetically modified (GM) food crops on a conditional basis.

Jubilant Life Sciences is up nearly 6% at Rs 131, extending its Fridays 8% rally on the NSE after
the company said its manufacturing facility at Montreal, Canada, has got a clean chit from the
US Food and Drug Administration (US FDA).

HT Media has surged nearly 5% to Rs 80.90 after Rakesh Jhunjhunwala bought 1.5 million
shares in the company though open market.
Stocks of companies associated with the railways are trading higher by up to 17% in noon deals
on media reports that the government is likely to take up new norms for liberalising the foreign
direct investment (FDI) regime in railways.
Kernex Microsystems (India), Kalindee Rail Nirman (Engineers), Titagarh Wagons, Texmaco Rail
and Engineering and Hind Rectifiers are up 7-17% on the Bombay Stock Exchange (BSE).